AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35073986 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant potato starch (RPS), 15 g per day
Number of subjects: 36
Study 35073986 — intervention group
Group type: COMPARATOR
Intervention: Cornstarch (digestible starch control), 15 g per day
Number of subjects: 36
Study 33441315 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-operative treatment pathway (broad-spectrum antibiotics and active observation)
Number of subjects: 50
Study 33441315 — intervention group
Group type: COMPARATOR
Intervention: Appendicectomy
Number of subjects: 50
Study 34033271 — intervention group
Group type: EXPERIMENTAL
Intervention: Terminal insomnia
Number of subjects: 0
Study 34033271 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial/middle insomnia
Number of subjects: 0
Study 32304983 — intervention group
Group type: EXPERIMENTAL
Intervention: Female MS patients
Number of subjects: 200
Study 32304983 — intervention group
Group type: EXPERIMENTAL
Intervention: Male MS patients
Number of subjects: 200
Study 32304983 — intervention group
Group type: COMPARATOR
Intervention: Healthy females
Number of subjects: 200
Study 32304983 — intervention group
Group type: COMPARATOR
Intervention: Healthy males
Number of subjects: 200
Study 36395635 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention group (YG) received a 60-min structured yoga module online for 3 months in addition to standard medical care.
Number of subjects: 120
Study 36395635 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention group (YG)
Number of subjects: 120
Study 36395635 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) received only standard care during the same period.
Number of subjects: 120
Study 33782657 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive children
Number of subjects: 482
Study 33782657 — intervention group
Group type: COMPARATOR
Intervention: HIV-negative children
Number of subjects: 482
Study 33782657 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive status
Number of subjects: 482
Study 34863332 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenzilumab (600 mg per dose, three doses delivered 8 hours apart)
Number of subjects: 520
Study 34863332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study 34863332 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenzilumab
Number of subjects: 520
Study 32712342 — intervention group
Group type: EXPERIMENTAL
Intervention: Real anodal tDCS
Number of subjects: 28
Study 32712342 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 28
Study 36194764 — intervention group
Group type: EXPERIMENTAL
Intervention: NG/CT treatment records (n = 30,365)
Number of subjects: 190589
Study 36194764 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment records associated with gonorrhea and/or chlamydia (n = 67,895)
Number of subjects: 190589
Study 36194764 — intervention group
Group type: COMPARATOR
Intervention: Testing episodes not associated with treatment records (n = 122,694)
Number of subjects: 190589
Study 36194764 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day treatment for NG/CT testing episodes
Number of subjects: 190589
Study 33693791 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher vegetable intake (per heaped tablespoon increase)
Number of subjects: 432732
Study 33693791 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic score for vegetable intake (per ordinal category increase)
Number of subjects: 432732
Study 33693791 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted vegetable intake (2-sample MR)
Number of subjects: 432732
Study 32780636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose prolotherapy (DPT) (20% dextrose/0.2% lidocaine)
Number of subjects: 29
Study 32780636 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine injection (0.2% lidocaine in sterile water)
Number of subjects: 29
Study 36181074 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF) switching group
Number of subjects: 30
Study 36181074 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV) continuing group
Number of subjects: 30
Study 36181074 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis of HBsAg decline
Number of subjects: 30
Study 36181074 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF) switching group with baseline eGFR < 60
Number of subjects: 30
Study 36181074 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV) continuing group with baseline eGFR < 60
Number of subjects: 30
Study 33780506 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple information treatment (explained that added sugars information was now available on the NF label)
Number of subjects: 490
Study 33780506 — intervention group
Group type: EXPERIMENTAL
Intervention: Full information treatment (included additional details on interpreting added sugars content and associated diseases)
Number of subjects: 490
Study 33780506 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessing added sugars information
Number of subjects: 490
Study 35558969 — intervention group
Group type: EXPERIMENTAL
Intervention: ApOx (apneic oxygenation) via low-flow nasal cannula (1 LPM for 0–1 month, 2 LPM for 1–12 months, 4 LPM for 1–7 years)
Number of subjects: 64
Study 35558969 — intervention group
Group type: COMPARATOR
Intervention: Classical rapid sequence induction (no oxygen supplementation)
Number of subjects: 64
Study 35558969 — intervention group
Group type: EXPERIMENTAL
Intervention: ApOx (apneic oxygenation)
Number of subjects: 64
Study 35558969 — intervention group
Group type: COMPARATOR
Intervention: Classical rapid sequence induction
Number of subjects: 64
Study 34506548 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR-BT
Number of subjects: 36
Study 34506548 — intervention group
Group type: COMPARATOR
Intervention: Treadmill Test
Number of subjects: 36
Study 35090674 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical monitoring with implantable cardiac monitors
Number of subjects: 400
Study 35090674 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 400
Study 34043051 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage during chemotherapy (4 sessions, 7 min each foot, 40 min intervals)
Number of subjects: 88
Study 34043051 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 88
Study 32954737 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial surgery followed by adjuvant chemotherapy
Number of subjects: 632
Study 32954737 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy followed by cytoreductive surgery
Number of subjects: 632
Study 34345908 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 26
Study 34345908 — intervention group
Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME)
Number of subjects: 26
Study 34345908 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RME and SME
Number of subjects: 26
Study 33271505 — intervention group
Group type: EXPERIMENTAL
Intervention: C+UST (Cognitive training + Unstable Strength Training)
Number of subjects: 50
Study 33271505 — intervention group
Group type: COMPARATOR
Intervention: UST (Unstable Strength Training)
Number of subjects: 50
Study 32486838 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 575
Study 36253166 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride plus potassium iodide (SDF + KI)
Number of subjects: 108
Study 36253166 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF)
Number of subjects: 108
Study 36253166 — intervention group
Group type: COMPARATOR
Intervention: Resin-modified glass ionomer cement (RMGIC)
Number of subjects: 108
Study 33306556 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced-prophylaxis (fluconazole 100 mg/day, azithromycin, isoniazid, cotrimoxazole)
Number of subjects: 1781
Study 33306556 — intervention group
Group type: COMPARATOR
Intervention: Standard-prophylaxis (cotrimoxazole)
Number of subjects: 1781
Study 32612266 — intervention group
Group type: EXPERIMENTAL
Intervention: 3mensio (3m) software
Number of subjects: 100
Study 32612266 — intervention group
Group type: COMPARATOR
Intervention: HeartNavigator3 (HN) software
Number of subjects: 100
Study 32612266 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthesis choice simulation based on HN-measurements
Number of subjects: 100
Study 36301896 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of intrinsic values of sentient beings
Number of subjects: 1508
Study 36301896 — intervention group
Group type: EXPERIMENTAL
Intervention: Concern for animal welfare
Number of subjects: 1508
Study 34289879 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based health educational intervention administered by Female Community Health Volunteers (FCHVs)
Number of subjects: 1143
Study 32346711 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical doxycycline for 5 min before replantation
Number of subjects: 38
Study 32346711 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 38
Study 36361001 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented activities of daily living (T-ADL) training
Number of subjects: 33
Study 36361001 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy (OT)
Number of subjects: 33
Study 35644154 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 600 mg
Number of subjects: 1549
Study 35644154 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 1200 mg
Number of subjects: 1549
Study 35644154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1549
Study 34218469 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal split-thickness envelope flap (MSTEF)
Number of subjects: 28
Study 34218469 — intervention group
Group type: COMPARATOR
Intervention: Flap
Number of subjects: 28
Study 36082909 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterally delivered glutamine (0.5 g/kg/day)
Number of subjects: 1200
Study 36082909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 34116828 — intervention group
Group type: EXPERIMENTAL
Intervention: BDCA score (Brain Death After Cardiac Arrest Score)
Number of subjects: 569
Study 32856530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically-expanded transcatheter heart valve
Number of subjects: 576
Study 32856530 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding transcatheter heart valve
Number of subjects: 576
Study 32856530 — intervention group
Group type: COMPARATOR
Intervention: Normal/normal gait speed
Number of subjects: 576
Study 32856530 — intervention group
Group type: COMPARATOR
Intervention: Slow/normal gait speed
Number of subjects: 576
Study 32856530 — intervention group
Group type: COMPARATOR
Intervention: Normal/slow gait speed
Number of subjects: 576
Study 32856530 — intervention group
Group type: COMPARATOR
Intervention: Slow/slow gait speed
Number of subjects: 576
Study 32856530 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow gait speed at 1 year (regardless of baseline speed)
Number of subjects: 576
Study 32856530 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalization of slow gait speed at 1 year
Number of subjects: 576
Study 32856530 — intervention group
Group type: EXPERIMENTAL
Intervention: One-year gait speed
Number of subjects: 576
Study 35691283 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 0
Study 35691283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35691283 — intervention group
Group type: COMPARATOR
Intervention: Ertugliflozin and Placebo
Number of subjects: 0
Study 32048768 — intervention group
Group type: EXPERIMENTAL
Intervention: Any irAE
Number of subjects: 186
Study 32048768 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade ≥3 irAE
Number of subjects: 186
Study 32048768 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional cycle of treatment
Number of subjects: 186
Study 32048768 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated lactate dehydrogenase
Number of subjects: 186
Study 35956320 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-killed Lactococcus lactis subsp. cremoris H61
Number of subjects: 0
Study 35956320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34398800 — intervention group
Group type: EXPERIMENTAL
Intervention: TrackPAD mobile intervention (3 months)
Number of subjects: 39
Study 34398800 — intervention group
Group type: COMPARATOR
Intervention: Routine care only (control group)
Number of subjects: 39
Study 34398800 — intervention group
Group type: EXPERIMENTAL
Intervention: TrackPAD mobile intervention
Number of subjects: 39
Study 35686212 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary nasal high flow (NHF) therapy
Number of subjects: 200
Study 35686212 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 200
Study 32981552 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age <35 years
Number of subjects: 1265
Study 32981552 — intervention group
Group type: COMPARATOR
Intervention: Maternal age ≥35 years
Number of subjects: 1265
Study 32981552 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum oestradiol (E2) level >90th percentile
Number of subjects: 1265
Study 32981552 — intervention group
Group type: COMPARATOR
Intervention: Serum oestradiol (E2) level ≤90th percentile
Number of subjects: 1265
Study 32981552 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy outcome positive
Number of subjects: 1265
Study 32981552 — intervention group
Group type: COMPARATOR
Intervention: Pregnancy outcome negative
Number of subjects: 1265
Study 35358827 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclined-adaptive footwear (IAF)
Number of subjects: 13
Study 35358827 — intervention group
Group type: COMPARATOR
Intervention: Footwear without adaptive technology (Control)
Number of subjects: 13
Study 33761873 — intervention group
Group type: COMPARATOR
Intervention: Cadmium concentrations (0, 15, 30, 45, and 60 mg L-1) for 60 days
Number of subjects: 0
Study 32221554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Number of subjects: 39
Study 32221554 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 39
Study 34184965 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser combined with kinesiology taping (LLL-KT)
Number of subjects: 30
Study 34184965 — intervention group
Group type: EXPERIMENTAL
Intervention: High power laser combined with kinesiology taping (HPL-KT)
Number of subjects: 30
Study 34184965 — intervention group
Group type: COMPARATOR
Intervention: Sham kinesiology taping (sham-KT)
Number of subjects: 30
Study 34000676 — intervention group
Group type: EXPERIMENTAL
Intervention: DUI enforcement intensity
Number of subjects: 109
Study 34000676 — intervention group
Group type: EXPERIMENTAL
Intervention: License suspension
Number of subjects: 109
Study 34000676 — intervention group
Group type: EXPERIMENTAL
Intervention: Jail penalties (1-3 days and 1-2 months)
Number of subjects: 109
Study 34000676 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine penalty and license points
Number of subjects: 109
Study 34000676 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlegal factors (informal sanction threat and vicarious experiences)
Number of subjects: 109
Study 32445558 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60
Study 32445558 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 60
Study 35305276 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized power training (IPT)
Number of subjects: 49
Study 35305276 — intervention group
Group type: COMPARATOR
Intervention: Generic power training (GPT)
Number of subjects: 49
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Needing others to help read materials (English)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Needing others to help read materials (Spanish)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Problems learning because of difficulty reading (English)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Problems learning because of difficulty reading (Spanish)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence with completing forms (English)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence with completing forms (Spanish)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined health literacy screening items (English)
Number of subjects: 2770
Study 32200999 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined health literacy screening items (Spanish)
Number of subjects: 2770
Study 33802709 — intervention group
Group type: EXPERIMENTAL
Intervention: Well Formulated Ketogenic Diet (WFKD)
Number of subjects: 0
Study 33802709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Plus (Med-Plus)
Number of subjects: 0
Study 33802709 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-provided food phase
Number of subjects: 0
Study 33802709 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivered food phase
Number of subjects: 0
Study 32434709 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional methods (n=101, 48%)
Number of subjects: 212
Study 32434709 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Recruitment (n=60, 28%)
Number of subjects: 212
Study 32434709 — intervention group
Group type: EXPERIMENTAL
Intervention: Health professional referrals (n=33, 16%)
Number of subjects: 212
Study 32434709 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 212
Study 32434709 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Recruitment
Number of subjects: 212
Study 33966536 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 stalking behavioral items from the National Stalking Helpline
Number of subjects: 924
Study 33966536 — intervention group
Group type: EXPERIMENTAL
Intervention: Item response theory analyses
Number of subjects: 924
Study 32658516 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert discussing spanking research with anti-spanking lay comments
Number of subjects: 180
Study 32658516 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert discussing spanking research with pro-spanking lay comments
Number of subjects: 180
Study 32658516 — intervention group
Group type: COMPARATOR
Intervention: Car seat expert
Number of subjects: 180
Study 36350591 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 208
Study 36350591 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (10 to 20 mg, flexibly dosed) for 8 weeks
Number of subjects: 208
Study 36350591 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MBSR vs Escitalopram
Number of subjects: 208
Study 36350591 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 208
Study 36350591 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR
Number of subjects: 208
Study 33622114 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib in combination with fulvestrant
Number of subjects: 0
Study 33622114 — intervention group
Group type: COMPARATOR
Intervention: Fulvestrant alone
Number of subjects: 0
Study 33034360 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartSurfACE
Number of subjects: 2
Study 33034360 — intervention group
Group type: COMPARATOR
Intervention: Streamlight
Number of subjects: 2
Study 32993426 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute mindfulness training plus 5-minute retreatment
Number of subjects: 209
Study 32993426 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 209
Study 32304828 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic and resistance group exercise intervention, 52 weeks, 3 sessions/week, 1 hour/session (n=110)
Number of subjects: 220
Study 32304828 — intervention group
Group type: COMPARATOR
Intervention: Support group intervention (attention-control arm), 52 weeks, 1 hour/week (n=110)
Number of subjects: 220
Study 36445709 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recruitment method
Number of subjects: 104
Study 36445709 — intervention group
Group type: COMPARATOR
Intervention: Traditional recruitment method
Number of subjects: 104
Study 34779114 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage surgical protocol without ridge augmentation (Group A)
Number of subjects: 79
Study 34779114 — intervention group
Group type: COMPARATOR
Intervention: Two-stage surgical protocol with ridge augmentation (Group B)
Number of subjects: 79
Study 34779114 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 79
Study 32690783 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided education and self-help website in addition to usual care
Number of subjects: 186
Study 32690783 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 186
Study 32960651 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Mind program
Number of subjects: 0
Study 32960651 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data
Number of subjects: 0
Study 32964474 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D robustly optimized IMPT plans
Number of subjects: 10
Study 32964474 — intervention group
Group type: COMPARATOR
Intervention: 3D robustly optimized IMPT plans
Number of subjects: 10
Study 35843520 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab (monotherapy or in combination with topical corticosteroids)
Number of subjects: 1976
Study 34463409 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg, 25 mg)
Number of subjects: 7020
Study 34463409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study 34983461 — intervention group
Group type: EXPERIMENTAL
Intervention: Group PM+ (gPM+) with enhanced care as usual (E-CAU)
Number of subjects: 46
Study 34983461 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual (E-CAU) only
Number of subjects: 46
Study 32350730 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare centers
Number of subjects: 297
Study 32350730 — intervention group
Group type: EXPERIMENTAL
Intervention: CACFP participants
Number of subjects: 297